Dopaminergic agonists impair latent learning in mice: possible modulation by noradrenergic function

Area of Science:

• Neuroscience
• Behavioral Pharmacology

Background:

• Latent learning, the acquisition of information without immediate reward or punishment, is crucial for adaptive behavior.
• Dopaminergic pathways are implicated in various cognitive functions, including learning and memory.

Purpose of the Study:

• To investigate the impact of dopamine agonists on latent learning in a mouse model.
• To explore the role of specific dopamine receptor subtypes and noradrenergic systems in modulating this effect.

Main Methods:

• A one-trial water-finding task in mice was employed to assess latent learning.
• Mice received various dopamine agonists (apomorphine, GBR-12909, nomifensine, methamphetamine) or vehicle before training.
• The effects were further examined using dopamine antagonists, a noradrenaline uptake inhibitor, and noradrenaline depletion.

Main Results:

• All tested dopamine agonists significantly impaired the development of latent learning.
• Apomorphine and GBR-12909 showed stronger disruptive effects than nomifensine and methamphetamine.
• Dopamine D2 antagonist (-)-sulpiride counteracted apomorphine's effect, while D1 antagonist SCH 23390 did not.
• Concurrent administration with desipramine reduced GBR-12909's impairment, and noradrenaline depletion impeded latent learning.

Conclusions:

• Activation of dopaminergic systems by agonists suppresses the acquisition of latent learning.
• The observed differences in agonist effects may relate to their influence on noradrenergic transmission.
• These findings highlight the intricate interplay between dopaminergic and noradrenergic systems in cognitive processes.